About: Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea
Creator	Sung, Heungsup Ki, Chang-Seok Kim, Jae-Seok Kim, Mi-Na Lee, Hyukmin Seong, Moon-Woo Yong, Dongeun Lee, Mi-Kyung Choi, Jong-Rak Kim, Jeong-Ho Kim, Sinyoung Lim, Yong Kweon, Joo
source	Medline; PMC
abstract	BACKGROUND: It is crucial to understand the current status of clinical laboratory practices for the largest outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in the Republic of Korea to be well prepared for future emerging infectious diseases. METHODS: We conducted a survey of 49 clinical laboratories in medical institutions and referral medical laboratories. A short questionnaire to survey clinical laboratory practices relating to MERS-CoV diagnostic testing was sent by email to the directors and clinical pathologists in charge of the clinical laboratories performing MERS-CoV testing. The survey focused on testing volume, reporting of results, resources, and laboratory safety. RESULTS: A total of 40 clinical laboratories responded to the survey. A total of 27,009 MERS-CoV real-time reverse transcription PCR (rRT-PCR) tests were performed. Most of the specimens were sputum (73.5%). The median turnaround time (TAT) was 5.29 hr (first and third quartile, 4.11 and 7.48 hr) in 26 medical institutions. The median TAT of more than a half of the laboratories (57.7%) was less than 6 hr. Many laboratories were able to perform tests throughout the whole week. Laboratory biosafety preparedness included class II biosafety cabinets (100%); separated pre-PCR, PCR, and post-PCR rooms (88.6%); negative pressure pretreatment rooms (48.6%); and negative pressure sputum collection rooms (20.0%). CONCLUSIONS: Clinical laboratories were able to quickly expand their diagnostic capacity in response to the 2015 MERS-CoV outbreak. Our results show that clinical laboratories play an important role in the maintenance and enhancement of laboratory response in preparation for future emerging infections.
has issue date	2015-12-18(xsd:dateTime)
bibo:doi	10.3343/alm.2016.36.2.154
bibo:pmid	26709263
has license	cc-by-nc
sha1sum (hex)	6db877f61327ae24341591d620abda3793639462
schema:url	https://doi.org/10.3343/alm.2016.36.2.154
resource representing a document's title	Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea
has PubMed Central identifier	PMC4713849
has PubMed identifier	26709263
schema:publication	Ann Lab Med
resource representing a document's body	covid:6db877f61327ae24341591d620abda3793639462#body_text
is schema:about of	named entity 'PRACTICES' named entity 'REPUBLIC OF KOREA' named entity 'INFECTIONS' named entity 'CURRENT' named entity 'EMERGING INFECTIOUS DISEASES' named entity 'BACKGROUND' named entity 'LARGEST' named entity 'UNDERSTAND' named entity 'PREPARED' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'CLINICAL LABORATORY' named entity 'SURVEY' named entity '2015' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'FUTURE' named entity 'OUTBREAK' named entity 'OUTBREAK' named entity 'PRACTICES' named entity 'STATUS' named entity 'CLINICAL LABORATORY' named entity 'REPUBLIC OF KOREA' covid:arg/6db877f61327ae24341591d620abda3793639462 named entity 'Republic of Korea' named entity 'clinical laboratory' named entity 'Republic of Korea' named entity 'MERS-CoV' named entity 'H1N1' named entity 'Middle East respiratory syndrome coronavirus' named entity 'MERS-CoV' named entity 'emerging infections' named entity 'MERS-CoV' named entity 'rRT-PCR' named entity 'rRT-PCR' named entity 'rRT-PCR' named entity 'sputum' named entity 'MERS-CoV' named entity 'MERS-CoV' named entity 'clinical laboratories' named entity 'public health laboratories' named entity 'diagnostic testing' named entity 'ECDC' named entity 'European Centre for Disease Prevention and Control' named entity 'H1N1' named entity 'H1N1' named entity 'MERS-CoV' named entity 'emerging pathogens' named entity 'H1N1' named entity 'etiology' named entity 'chi-square test' named entity 'diagnostic tests' named entity 'MERS-CoV' named entity 'public health laboratories' named entity 'molecular testing' named entity 'standard precautions' named entity 'United Arab Emirates' named entity 'clinical pathologists' named entity 'molecular diagnostic' named entity 'lower respiratory tract' named entity 'infection' named entity 'virus' named entity '57.7%' named entity 'clinical laboratory' named entity 'medical laboratories' named entity 'clinical laboratories' named entity 'medical laboratories' named entity 'rRT-PCR' named entity 'emerging infectious diseases' named entity 'MERS-CoV' named entity 'rRT-PCR'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software